Drug Shortage Report for MYLAN-BUPROPION XL

Last updated on 2019-06-19 History
Report ID 3941
Drug Identification Number 02382075
Brand name MYLAN-BUPROPION XL
Common or Proper name BUPROPION XL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-18
Actual start date 2018-05-04
Estimated end date 2019-09-30
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments Manufacturing issues
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v87 2018-05-11 English Compare
v86 2018-05-09 French Compare
v85 2018-05-09 English Compare
v84 2018-05-04 French Compare
v83 2018-05-04 English Compare
v82 2018-05-03 French Compare
v81 2018-05-03 English Compare
v80 2018-05-01 French Compare
v79 2018-05-01 English Compare
v78 2018-04-27 French Compare
v77 2018-04-27 English Compare
v76 2018-02-28 French Compare
v75 2018-02-28 English Compare
v74 2018-02-27 French Compare
v73 2018-02-27 English Compare
v72 2018-02-23 French Compare
v71 2018-02-23 English Compare
v70 2018-02-16 French Compare
v69 2018-02-16 English Compare
v68 2018-02-14 English Compare

Showing 41 to 60 of 127